APGE

Apogee Therapeutics, Inc.

NasdaqHealthcareBiological Products, (No Diagnostic Substances)

Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingSep 03, 2026Most recent Form 4
Total buying$00 buys
Total selling$00 sells
Net open-market+$04 insiders
Open-market mix
Buy vs sell distribution by transaction count
0 transactions

Insider activity report

Monthly open-market purchase and sale counts
Buys Sells
530-3-5transactionsAugSep

Transaction codes

By Form 4 transaction code in selected period
8transactions
  • D · Issuer dispositions · dominant8 · 100%

Activity by reported role

A joint filing can contribute to multiple roles
8transactions
  • Director · dominant8 · 100%

Distinct insiders active

Reporting-owner CIKs by month · peak Sep 2026 (4)
Aug 2026Sep 2026
4distinct insiders in 2 months

Reported Holdings After

Separated by insider, security, and ownership type
Harwin Peter EvanStock Option (Right to Buy) · Indirect · By Tomas Kiselak
00Sep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026Sep 03, 2026
0Sep 03, 2026
Fairmount Healthcare Fund II L.P.Stock Option (Right to Buy) · Indirect · By Tomas Kiselak
00Sep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026Sep 03, 2026
0Sep 03, 2026
Fairmount Funds Management LLCStock Option (Right to Buy) · Indirect · By Tomas Kiselak
00Sep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026Sep 03, 2026
0Sep 03, 2026
Kiselak TomasStock Option (Right to Buy) · Indirect · By Tomas Kiselak
00Sep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026 · 0 shares owned afterSep 03, 2026Sep 03, 2026
0Sep 03, 2026
Harwin Peter EvanCommon Stock · Indirect · By Peter Harwin
00Sep 03, 2026 · 0 shares owned afterSep 03, 2026Sep 03, 2026
0Sep 03, 2026
Harwin Peter EvanNon-Voting Common Stock · Indirect · By Fairmount Healthcare Fund II LP
00Sep 03, 2026 · 0 shares owned afterSep 03, 2026Sep 03, 2026
0Sep 03, 2026
Harwin Peter EvanCommon Stock · Indirect · By Fairmount Healthcare Fund II LP
00Sep 03, 2026 · 0 shares owned afterSep 03, 2026Sep 03, 2026
0Sep 03, 2026
Harwin Peter EvanCommon Stock · Indirect · By Tomas Kiselak
00Sep 03, 2026 · 0 shares owned afterSep 03, 2026Sep 03, 2026
0Sep 03, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
1 active days
Aug 04Sep 04
LessMore
Top insiders
By absolute net value across the selected period
1 insiders
Recent filing activity
Most recent 8 transactions · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale-
10b5-1 detected0
Amended rows0

Filing-only signals

Deterministic matches in the selected period

No filing-only signal badges matched this period.

APGE transaction history

Filters apply within this company and selected period by default
Reset
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
APGEFairmount Funds Management LLC
DIR
return7.65kD0.0%09/0309/03
APGEFairmount Funds Management LLC
DIR
return14.4kD0.0%09/0309/03
APGEFairmount Funds Management LLC
DIR
return10.3kD0.0%09/0309/03
APGEFairmount Funds Management LLC
DIR
return47.7kD0.0%09/0309/03
APGEFairmount Funds Management LLC
DIR
return6.74MD0.0%09/0309/03
APGEFairmount Funds Management LLC
DIR
return51.1kD0.0%09/0309/03
APGEFairmount Funds Management LLC
DIR
return51.1kD0.0%09/0309/03
APGEFairmount Funds Management LLC
DIR
return340kD0.0%09/0309/03

Apogee Therapeutics, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Apogee Therapeutics, Inc.?

Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Harwin Peter Evan, Kiselak Tomas.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

No code-P purchases or code-S sales were reported in the selected period.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.